Explore / Peer-reviewed article
Peer-reviewed article

Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.

Wang HiD, Wang XiD

ACS chemical neuroscienceApr 20, 2025China5 citationsDOI: 10.1021/acschemneuro.5c00247

Abstract

This viewpoint explores the therapeutic potential of psychedelics in treating neuropsychiatric disorders, particularly through the modulation of brain entropy and the experience of ego dissolution. Psychedelics disrupt rigid neural patterns, facilitating enhanced connectivity and fostering profound emotional breakthroughs that may alleviate symptoms of disorders like depression, anxiety, PTSD, and addiction. Despite their promising potential, the clinical application of psychedelics presents significant challenges, including the need for careful patient screening, managing adverse experiences, and addressing ethical considerations, all of which are essential for their safe integration into therapy.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinLSDDepressionPTSDAnxietyAddiction

Keywords

Lysergic Acid DiethylamideEgoDefault Mode NetworkNeuropsychiatric DiseasesPsychedelics

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.